Clinical next-generation sequencing in patients with non-small cell lung cancer

Author:

Hagemann Ian S.1,Devarakonda Siddhartha2,Lockwood Christina M.1,Spencer David H.1,Guebert Kalin2,Bredemeyer Andrew J.1,Al-Kateb Hussam1,Nguyen TuDung T.1,Duncavage Eric J.1,Cottrell Catherine E.1,Kulkarni Shashikant1,Nagarajan Rakesh1,Seibert Karen1,Baggstrom Maria2,Waqar Saiama N.2,Pfeifer John D.1,Morgensztern Daniel2,Govindan Ramaswamy2

Affiliation:

1. Division of Laboratory and Genomic Medicine; Department of Pathology and Immunology; Washington University; St. Louis Missouri

2. Section of Medical Oncology, Division of Hematology and Oncology, Department of Medicine; Washington University; St. Louis Missouri

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference30 articles.

1. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N Engl J Med,2002

2. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

3. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

4. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer;Kwak;N Engl J Med,2010

5. Clinical activity of crizotinib in advanced non-small cell lung cancer (NSCLC) harboring ROS1 gene rearrangement;Shaw;ASCO Meet Abstr,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3